New antiviral treatment for COVID-19 will be mostly set aside for use in older unvaccinated individuals and immunocompromised Ontarians
A new antiviral drug that can be used to treat COVID-19 will be primarily set aside for use in older unvaccinated individuals and immunocompromised Ontarians.
The Ford government has released new eligibility guidelines that provide the first look at how it will distribute its limited supply of Pfizer’s Paxlovid pill, the first shipment of which arrived in the province last week.
The government says that it is prioritizing individuals at “the highest risk of severe outcomes,” including unvaccinated Ontarians age 60 and up and unvaccinated Ontarians aged 50 and up who also have one or more specific risk factors.
The government will also make all immunocompromised individuals aged 18 and up eligible, regardless of their vaccination status, as well as all unvaccinated First Nation, Inuit and Métis individuals aged 50 and up.
In order to access the drug those eligible will have to first test positive for COVID-19 and the Ford government says that it is now introducing “expanded COVID-19 assessment centres” where Ontarians will be able to access both testing and “outpatient therapeutics,” such as Paxlovid.
It says that the testing centres will have access to multiple testing options, including rapid tests, to asses those who may be eligible for treatment.
However, not all assessment centres will have the drug on hand.
According to data from the clinical trials, the Paxlovid pill was found to be 89 per cent effective at reducing the risk of hospitalization and death after a full course of treatment (three pills twice daily for five days in a row).
The Ontario government has said that it expects to receive approximately 10,000 courses of treatment in January.
“Given the very limited supply of antivirals, not all patients who meet the clinical eligibility criteria will be guaranteed access to treatment,” the government warns on a new website set up to provide information about antiviral treatments.
Paxlovid was approved by Health Canada on Jan. 17.
CTVNews.ca Top Stories
'A beautiful soul': Funeral held for baby boy killed in wrong-way crash on Highway 401
A funeral was held on Wednesday for a three-month-old boy who died after being involved in a wrong-way crash on Highway 401 in Whitby last week.
'Sophisticated' cyberattacks detected on B.C. government networks, premier says
There has been a "sophisticated" cybersecurity breach detected on B.C. government networks, Premier David Eby confirmed Wednesday evening.
Police handcuff man trying to enter Drake's Toronto mansion
Toronto police say a man was taken into custody outside Drake's Bridle Path mansion Wednesday afternoon after he tried to gain access to the residence.
Biden says he will stop sending bombs and artillery shells to Israel if they launch major invasion of Rafah
U.S. President Joe Biden said for the first time Wednesday he would halt shipments of American weapons to Israel, which he acknowledged have been used to kill civilians in Gaza, if Prime Minister Benjamin Netanyahu orders a major invasion of the city of Rafah.
Canucks claw out 5-4 comeback win over Oilers in Game 1
Dakota Joshua had a goal and two assists and the Vancouver Canucks scored three third-period goals to claw out a 5-4 comeback victory over the Edmonton Oilers in Game 1 of their second-round playoff series Wednesday.
Nijjar murder suspect says he had Canadian study permit in immigration firm's video
One of the Indian nationals accused of murdering British Columbia Sikh activist Hardeep Singh Nijjar says in a social media video that he received a Canadian study permit with the help of an Indian immigration consultancy.
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Quebec premier defends new museum on Quebecois nation after Indigenous criticism
Quebec Premier Francois Legault is defending his comments about a new history museum after he was accused by a prominent First Nations group of trying to erase their history.
U.S. presidential candidate RFK Jr. had a brain worm, has recovered, campaign says
Independent U.S. presidential candidate Robert F. Kennedy Jr. had a parasite in his brain more than a decade ago, but has fully recovered, his campaign said, after the New York Times reported about the ailment.